Which hedge funds own JANX? JANUX THERAPEUTICS INC, Q2 2026 13F holders
44 tracked hedge funds disclosed a position in JANX (JANUX THERAPEUTICS INC) in their Q2 2026 13F filings, worth $428.5m in total. The largest holder by portfolio weight is Prosight Management, LP at 10.1% of its book. 7 opened a new position this quarter: Verdad Advisers, LP, CenterBook Partners LP, Trexquant Investment LP, AQR Capital Management LLC. 9 exited: Irenic Capital Management LP, Logos Global Management LP, Deep Track Capital, LP.
- 44
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $4.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $45.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $429m
- Combined value Sum of the holders' reported positions in the security.
- 3.6%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Irenic Capital Management LP | 1.0% | $10.6m |
| Logos Global Management LP | 0.7% | $13.9m |
| Deep Track Capital, LP | 0.3% | $16.5m |
| Stonepine Capital Management, LLC | 0.2% | $278k |
| Readystate Asset Management LP | 0.09% | $1.5m |
| Aquatic Capital Management LLC | 0.04% | $1.3m |
| Weiss Asset Management LP | 0.02% | $1.3m |
| Caption Management, LLC | 0.0% | $20.7k |
| Bayforest Capital Ltd | 0.0% | $42 |
Ownership over time
Who discovered JANX first? Beta
The run: Q4 2023 → Q4 2024, +399%
| Orbimed Advisors LLC | Q1 2024 | 0.7% | +1.1 pts |
| Stempoint Capital LP | Q1 2024 | – | −1.0 pts |
| Cormorant Asset Management, LP high conviction | Q1 2024 | – | −3.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.